Under construction – not a live service
Sign in

What researchers published on Acute myeloid leukaemia

4,419 papers, newest first.

Showing 40 of 4,419

  • Acute Myeloid Leukemia in a Patient with Fontan Circulation - Case Report.Progress in pediatric cardiology
  • Optimizing Reduced-Intensity Conditioning for Older Patients with AML and MDS: A Large-Scale Analysis from the CIBMTR.Blood
  • Integrated multi-omics reveals methylation-linked biological heterogeneity in intermediate-risk pediatric acute myeloid leukemia.iScience
  • Low-dose 10-day decitabine plus venetoclax induced rapid MRD negativity and durable remission in De Novo AML.Annals of hematology
  • Two Immune States in Ex Vivo Venetoclax-Resistant AML: Antigen- Presentation Silencing versus Checkpoint Exhaustion.Current cancer drug targets
  • Retraction: Dickkopf 2 serves as a novel therapeutic target and prognostic biomarker in acute myeloid leukemia targeted by evodiamine.Frontiers in medicine
  • Precision Survival Estimation in Acute Myeloid Leukemia Using Evolutionary Learning-Derived microRNA Signature.Computational and structural biotechnology journal
  • Modulation of the RNA-sensing RIG/MAVS pathway bypasses resistance to hypomethylating agents in acute myeloid leukemia.HemaSphere
  • Allogeneic CD33/CD123 CAR-T сells in pediatric relapsed/refractory AML: early single-center experience.Transplantation and cellular therapy
  • New Phenazine 5,10-Dioxide Carbamates Inspired by Iodinin and Myxin Exhibit Improved Potency in Human Leukemia Cells with High Cytotoxic Selectivity, Activity against Mycobacterium Tuberculosis and Low Toxicity to Zebrafish Larvae.Journal of medicinal chemistry
  • Response to: Reassessing real-world FLT3 inhibitor maintenance patterns after allogeneic transplantation in acute myeloid leukemia.Journal of geriatric oncology
  • Exploring Efficacy and Predictors of Response to Venetoclax and Hypomethylating Agents in Newly Diagnosed Acute Myeloid Leukemia: A Real-World Study.International journal of cancer
  • Allogeneic hematopoietic stem cell transplantation is associated with improved long-term survival and molecular MRD clearance in KMT2A-altered AML.Annals of medicine
  • Teclistamab in multiple myeloma with coexisting myelodysplastic syndrome or acute myeloid leukemia.Haematologica
  • Discovery of Novel Pyridine-Dihydropyrrolo[3,4-b]Pyrrolidone Derivatives as Orally Active PIM Kinase Inhibitors for the Treatment of Acute Myeloid Leukemia.Journal of medicinal chemistry
  • Observational studyPaediatric Bone Marrow Transplant Outcomes.Journal of the College of Physicians and Surgeons--Pakistan : JCPSP
  • Outcomes of Venetoclax-Based Regimens Versus Intensive and Reduced-Intensity Chemotherapy in Newly Diagnosed AML.Cancer medicine
  • Proceedings of the 2025 society for Hematopathology/European association for Haematopathology workshop session 1: new entities in pediatric acute leukemia.Journal of hematopathology
  • Differentiation hierarchy in adult B-cell acute lymphoblastic leukemia at clonal resolution.Leukemia
  • A Rare 18F-FDG PET/CT Finding Mimicking Leukemia Cutis in Acute Myeloid Leukemia: Palisaded Neutrophilic Granulomatous Dermatitis.Clinical nuclear medicine
  • Disease biology rather than donor type determines transplant outcomes in KMT2A-rearranged AML.Annals of hematology
  • Case reportPulmonary embolism as the initial manifestation of acute promyelocytic leukemia: A case report and review of the literature.Medicine
  • Next-Generation Sequencing in Acute Myeloid Leukemia: Advancing Clinical Insights.Anti-cancer agents in medicinal chemistry
  • Reassessing real-world FLT3 inhibitor maintenance patterns after allogeneic transplantation in acute myeloid leukemia.Journal of geriatric oncology
  • Neither the pan-immune-inflammation value nor the PILE score improved on APACHE-II or SOFA in a single-center cohort of critically ill older patients with acute myeloid leukemia.Frontiers in medicine
  • NPM1-mutated AML: One entity, multiple layers of heterogeneity.British journal of haematology
  • Mediator kinase inhibition exposes a transcriptional vulnerability and synergizes with venetoclax in AML.Leukemia
  • Diagnostic agreement between ChatGPT-based interpretation of laboratory-generated flow cytometry graphical outputs and hematologist consensus in suspected acute leukemia.Cytometry. Part B, Clinical cytometry
  • Expression patterns of hypoxia signaling pathway genes and their association with clinical biochemical parameters in acute myeloid leukemia patients of Assam: A case control study.Molecular biology reports
  • Occurrence of FLT3 mutations in acute myeloid leukemia and comparison of different methodologies.BMC cancer
  • Evolutionary dynamics in the years preceding acute myeloid leukaemia.Nature
  • Dual epigenetic agents combined with venetoclax and CAG regimen as induction therapy in newly diagnosed ELN 2022 adverse-risk AML.Clinical epigenetics
  • Rare variants of NPM1 mutations share a similar molecular background to the common NPM1 type A variant and are associated with similar survival in adults with acute myeloid leukaemia.British journal of haematology
  • Phenanthridone derivative PTD031 exerts efficacy against acute myeloid leukemia through dual targeting of DNA and redox homeostasis.Bioorganic chemistry
  • BCR::ABL1 emergence during menin inhibitor therapy in two patients with relapsed or refractory acute myeloid leukemia.Leukemia & lymphoma
  • How I treat MDS/AML: individualizing therapy based on disease biology, patient fitness, molecular features, and treatment goals.Clinical advances in hematology & oncology : H&O
  • ReviewAdvances in CBFA2T3::GLIS2 fusion gene in pediatric acute myeloid leukemia: from molecular mechanisms to targeted therapeutic strategies.Annals of hematology
  • ADGRE2: A Promising Immunotherapeutic Target in Acute Myeloid Leukemia and Chronic Myelomonocytic Leukemia.Cancer medicine
  • Lessons and limitations of the PARADIGM trial in acute myeloid leukemia.Clinical advances in hematology & oncology : H&O
  • Case reportCutaneous polyarteritis nodosa preceding acute myeloid leukemia with plasmacytoid dendritic cell differentiation and leukemia cutis.JAAD case reports